P

Precigen
D

PGEN

1.13500
USD
-0.04
(-2.99%)
مغلق
حجم التداول
33,211
الربح لكل سهم
-0
العائد الربحي
-
P/E
-2
حجم السوق
332,406,425
أصول ذات صلة
    ALNY
    ALNY
    1.73
    (0.65%)
    266.69 USD
    B
    BEAM
    1.860
    (7.59%)
    26.380 USD
    B
    BLUE
    -0.31000
    (-3.79%)
    7.86000 USD
    C
    CRSP
    2.740
    (6.61%)
    44.200 USD
    E
    EDIT
    0.15000
    (12.50%)
    1.35000 USD
    N
    NTLA
    1.040
    (10.45%)
    10.990 USD
    REGN
    REGN
    -7.47
    (-1.09%)
    679.85 USD
    R
    RGNX
    0.28500
    (3.77%)
    7.85000 USD
    S
    SGMO
    0.03500
    (3.13%)
    1.15500 USD
    VRTX
    VRTX
    0.08
    (0.02%)
    428.09 USD
    المزيد
الأخبار المقالات

العنوان: Precigen

القطاع: Healthcare
الصناعة: Biotechnology
Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improvedproducts and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.